Prognostic molecular markers in non-small cell lung cancer
- 1 December 2001
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 34, S53-S58
- https://doi.org/10.1016/s0169-5002(01)00345-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Correlation of outcome of resected non-small-cell lung cancer (NSCLC) with p53 mutations detected by yeast functional assayLung Cancer, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Molecular pathogenesis of lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1999
- K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 casesCarcinogenesis: Integrative Cancer Research, 1999
- Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinomaOncogene, 1999
- Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Clinical tumour markers in lung cancerEuropean Journal Of Cancer Prevention, 1995
- Multifactorial analysis of p53 alteration in human cancer: A reviewInternational Journal of Cancer, 1994
- C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Journal of Clinical Investigation, 1994
- Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993